Quantum Genomics
ALQGC | PA
Overview
Corporate Details
- ISIN(s):
- FR0010783837 (+4 more)
- LEI:
- 969500TFCD8K9RPM9K97
- Country:
- France
- Address:
- 6 RUE CAMBACERES, 75008 PARIS
- Website:
- https://quantum-genomics.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure. Quantum Genomics is developing a new therapeutic approach based on Brain Aminopeptidase A inhibition (BAPAI) , which results from more than twenty years of academic research in the laboratories of the Collège de France, INSERM and CNRS. The research conducted by the team of Professor Bernard-Pierre Roques (INSERM U1022 / CNRS Unit/ Université Paris Descartes) and the team of Dr. Catherine Llorens-Cortes (INSERM U1050 / Collège de France) characterized the role of the brain renin-angiotensin system (RAS) and more particularly that of aminopeptidase A (APA) in the control of certain cardiovascular functions including blood pressure.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-30 20:00 |
Earnings Release
Quantum Genomics publishes its 2024 annual financial statements and announces a…
|
English | 206.5 KB | |
| 2025-04-30 20:00 |
Report Publication Announcement
Quantum Genomics publie ses comptes annuels 2024 et annonce un changement de li…
|
French | 254.0 KB | |
| 2025-04-08 08:00 |
Regulatory News Service
Quantum Genomics fait un point sur sa situation
|
French | 688.8 KB | |
| 2025-04-08 08:00 |
Takeover Announcement Report
Quantum Genomics provides an update on its situation
|
English | 626.0 KB | |
| 2024-10-29 18:00 |
Earnings Release
Quantum Genomics publie ses résultats du 1er semestre 2024 et annonce la nomina…
|
French | 241.2 KB | |
| 2024-09-27 08:00 |
Capital/Financing Update
Quantum Genomics sécurise un financement avec le fonds Akkadian Partners Fund e…
|
French | 74.5 KB | |
| 2024-09-04 18:00 |
Inside Information Statement
Quantum Genomics reviewed its financial situation and announced that it has fil…
|
English | 175.5 KB | |
| 2024-09-04 18:00 |
Inside Information Statement
Quantum Genomics fait un point sur sa situation financière et annonce qu'elle a…
|
French | 150.0 KB | |
| 2024-07-03 13:00 |
Capital/Financing Update
BILAN SEMESTRIEL S1 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE…
|
French | 275.3 KB | |
| 2024-03-13 18:00 |
Inside Information Statement
Quantum Genomics publie ses résultats de l'exercice 2023. Le rapprochement avec…
|
French | 193.8 KB | |
| 2024-03-13 18:00 |
Earnings Release
Quantum Genomics publishes its results for the 2023 financial year. The merger …
|
English | 166.3 KB | |
| 2024-01-10 16:35 |
Transaction in Own Shares
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | |
| 2024-01-10 16:30 |
Transaction in Own Shares
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | |
| 2023-12-14 18:05 |
Regulatory News Service
Quantum Genomics enters into exclusive negotiations with ExactCure
|
English | 286.1 KB | |
| 2023-12-14 18:00 |
Regulatory News Service
Quantum Genomics entre en négociation exclusive avec ExactCure
|
French | 324.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |